Trupanion Inc — MarketDX

0LH0.LSE

Trupanion Reports Second Quarter 2026 Earnings, Updates Guidance, and Announces Digitail Integration

Trupanion is back in focus after reporting second quarter 2026 earnings, issuing updated full year guidance, and unveiling a new integration agreement with veterinary software provider Digitail. The company's most followed narrative pegs fair value at $37.25, well above the recent $26.99 close, suggesting the stock could be 27.5% undervalued. This narrative builds on steady revenue growth, improved underwriting discipline, and a focus on higher lifetime value pets, which are expected to drive scalable and more profitable expansion. However, the current P/E of 51x sits well above the fair ratio of 15.2x and the US Insurance industry average of 11.5x, pointing to meaningful valuation risk if sentiment cools. The stock has fallen 27.45% year to date, with a one-year total shareholder return of negative 44.7%, though recent momentum shows a 9.67% gain over the past three months.

TRUP

Simply Wall St·40dRead more →

0LH0.LSE▲3

Trupanion Reports Mixed Q2 Results, Updates 2026 Guidance, and Announces Digitail Integration

Trupanion reported second-quarter 2026 results showing lower net income year over year but stronger first-half profitability, updated its 2026 guidance with expected total revenue of about US$1.58–US$1.60 billion and subscription revenue of roughly US$1.12–US$1.13 billion, and highlighted continued double-digit subscription growth. The company also unveiled an integration with veterinary software provider Digitail to embed its Veterinary Portal and VetDirect Pay tools directly into clinic workflows, alongside announcing an extraordinary US$44 million dividend from a subsidiary and a US$100 million share buyback authorization. These developments may influence how investors view Trupanion's capital allocation and growth strategy.

TRUP ▲

Simply Wall St·41dRead more →

0LH0.LSE▲2

Trupanion beats Q2 estimates, announces $100 million buyback and $44 million dividend

Trupanion posted second-quarter 2026 results that beat consensus estimates on both revenue and earnings, while also announcing a $100 million share buyback program and a $44 million extraordinary dividend approved by the New York Department of Financial Services. Total revenue rose 11% year over year to $393 million, subscription revenue grew 14% to $276.7 million, and adjusted EBITDA increased to $19.8 million from $16.6 million a year earlier. Earnings per share came in at 16 cents, down 27% from the prior year but 45% above the Zacks Consensus Estimate. The company narrowed its full-year 2026 total revenue guidance to between $1.584 billion and $1.601 billion and subscription revenue to between $1.124 billion and $1.133 billion, while also tightening its adjusted operating income outlook to a range of $176 million to $184 million. Despite the positive results, the stock trades at a premium valuation and analyst sentiment remains mixed, leading Zacks to maintain a Hold rating on the shares.

TRUP ▲

Zacks Investment Research·42dRead more →

0LH0.LSE▼

Trupanion Stock Drops 33.3% in Six Months, Analysts Advise Caution

Trupanion's stock price has fallen 33.3% over the last six months to $25.47 per share, prompting a cautious stance from analysts. The company's book value per share grew at an annual rate of 11.9% over the past two years, but consensus estimates project only 3.4% growth to $8.82 over the next 12 months. Additionally, Trupanion has posted an average return on equity of negative 6.5% over the last five years, underperforming most insurers. The stock currently trades at 2.6 times forward price-to-book, and analysts suggest there are more attractive opportunities elsewhere.

TRUP ▼

Yahoo Finance·80dRead more →